Resveratrol and Diabetic Retinopathy

• February 23, 2026

AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

• by Matthew Solan

• April 23, 2026

• 4 min

From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy

• by Zhiwei Xu, Shi Bai, Caidi He, Xiaobei Lv, Qin Li, Qile Mao, Haijian Wu, Peter Wang

• May 13, 2026

Association of Serum and Aqueous Humor Levels of miR-199a-3p and FN1 with the Severity of Type 2 Diabetic Retinopathy in a Chinese Cohort

• by Yang Chen, Nianlin Chen, Xiangrui Meng, Minli Linghu, Yikeng Huang, Xionggao Huang

• April 28, 2026